Oita, Japan

Tsuyoshi Kuroda


Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Nakatsu, JP (1985)
  • Oita, JP (1986 - 1989)
  • Chikujo-gun, JP (1997)

Company Filing History:


Years Active: 1985-1997

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Tsuyoshi Kuroda: Innovator in Antibacterial Compounds

Introduction

Tsuyoshi Kuroda is a prominent inventor based in Oita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. With a total of 4 patents to his name, Kuroda's work has the potential to impact the treatment of infectious diseases.

Latest Patents

Kuroda's latest patents include innovative compounds such as 8-methoxy-quinolonecarboxylic acid derivatives. These compounds exhibit a wide range of in vitro and in vivo antibacterial effects against Gram-positive bacteria, while also maintaining strong antibacterial activity against Gram-negative bacteria. The compounds are designed to have minimal side effects and low toxicity, making them promising candidates for clinical use as antibacterial agents. Another notable patent involves quinolonecarboxylic acid compounds, which also demonstrate antibacterial activities and are useful for treating various infectious diseases.

Career Highlights

Tsuyoshi Kuroda is currently associated with Yoshitomi Pharmaceutical Industries, Ltd., where he continues to innovate in the field of pharmaceuticals. His research focuses on developing effective antibacterial agents that can address the growing concern of antibiotic resistance.

Collaborations

Kuroda has collaborated with notable colleagues such as Akihiko Moriguchi and Yoshifumi Ikeda. These collaborations have further enhanced the research and development of new pharmaceutical compounds.

Conclusion

Tsuyoshi Kuroda's contributions to the field of antibacterial compounds highlight his role as an influential inventor. His innovative work has the potential to lead to significant advancements in the treatment of infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…